REAL-WORLD HEALTHCARE COSTS OF LATE-LINE MULTIPLE MYELOMA (MM) PATIENTS ON COMMON MONOTHERAPIES: A GERMAN CLAIMS DATA ANALYSIS

被引：0
|
作者：
Kocaata, Z. [1 ]
Wilke, T. [2 ]
Fischer, F. [3 ]
Welte, R. [3 ]
Einsele, H. [4 ]
机构：
[1] Ingress Hlth HWM GmbH, Wismar, MV, Germany
[2] Univ Wismar, IPAM, Wismar, Germany
[3] GlaxoSmithKline GmbH & Co KG, Munich, Germany
[4] Univ Cin Wuerzburg, Wurzburg, Germany
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN114
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [1] Real-world utilization and healthcare costs for multiple myeloma: A retrospective analysis of patients in Singapore
    Bayani, Diana Beatriz
    Lin, Yihao Clement
    Ooi, Melissa G.
    Tso, Allison Ching Yee
    Wee, Hwee Lin
    EJHAEM, 2023, 4 (04): : 1013 - 1018
  • [2] Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data
    Niegisch, Guenter
    Grimm, Marc-Oliver
    Hardtstock, Fraence
    Krieger, Julia
    Starry, Alexandra
    Osowski, Ulrike
    Deiters, Barthold
    Maywald, Ulf
    Wilke, Thomas
    Kearney, Mairead
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 531 - 542
  • [3] Line of Therapy Algorithm for Real-World Data Analysis in Multiple Myeloma
    Fajardo, Otto
    Sach-Peltason, Lisa
    Hernandez, Elsa Garcia
    Braun, Franziska
    Weisser, Martin
    Duque, Felipe A. Castro
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 425 - 425
  • [4] NON-ADHERENCE TO ORAL TREATMENTS IN PATIENTS WITH MULTIPLE MYELOMA: REAL-WORLD EVIDENCE FROM A GERMAN CLAIMS DATA
    Kocaata, Z.
    Mueller, S.
    Maywald, U.
    Wilke, T.
    VALUE IN HEALTH, 2020, 23 : S422 - S422
  • [5] Characteristics of Multiple Myeloma Patients with Multiple Lines of Therapy Using Real-World US Claims Data
    Maiese, Eric
    Macomson, Brian
    Kozma, Chris
    Slaton, Terra
    Senbetta, Mekre
    BLOOD, 2015, 126 (23)
  • [6] Multiple myeloma (MM): Loss of patients per treatment line in a single real-world center
    Steinmetz, T.
    Bergmann, M.
    Heinz, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 115 - 116
  • [7] Real-world treatment patterns, healthcare resource utilization (HRU), and costs of initial line of therapy (LOT1) in multiple myeloma (MM)
    Byfield, Stacey DaCosta
    Bancroft, Tim
    Ma, Esprit
    Bonthapally, Vijayveer
    Teitelbaum, April H.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [8] Pharmacogenetics of warfarin and healthcare costs - Real-world data analysis
    Lahteenmaki, Jaakko
    Vuorinen, Anna-Leena
    Lehto, Mika
    Niemi, Mikko
    Forsberg, Markus M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (03) : 382 - 386
  • [9] Real-World Trends in Treatment Use, Healthcare Costs, and Overall Survival Among Patients with Multiple Myeloma
    Fonseca, Rafael
    Abouzaid, Safiya
    Bonafede, Machaon
    Cai, Qian
    Parikh, Kejal
    Cosler, Leon
    Richardson, Paul
    BLOOD, 2016, 128 (22)
  • [10] Real-world healthcare resource utilization and costs among patients with multiple myeloma in the United States.
    Gupta, Niodita
    Tai, Ming-Hui
    Kaila, Shuchita
    Thompson-Leduc, Philippe
    Ghelerter, Isabelle
    Kurteva, Siyana
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18811 - E18811
12345